Postural orthostatic tachycardia syndrome is the most frequent cardiovascular autonomic disorder following COVID-19 infection or vaccination

Background Cardiovascular autonomic disorders (CAD) were described following COVID-19 infection and vaccination, but previous reports were limited in size and follow-up. Here, we aimed to investigate the type and frequency of newly diagnosed and exacerbated CAD following COVID-19 infection or vaccin...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of neurology Ročník 272; číslo 12; s. 783
Hlavní autori: Leys, Fabian, Verginer, Mara, Kirchler, Elias, Marino, Loraine, Goebel, Georg, Campese, Nicole, Eschlböck, Sabine, Duerr, Susanne, Broessner, Gregor, Djamshidian-Tehrani, Atbin, Heidbreder, Anna, Högl, Birgit, Rothmund-Grenier, Maria-Sophie, Hüfner, Katharina, Iglseder, Sarah, Löscher, Wolfgang, Stefani, Ambra, Wanschitz, Julia, Weiss, Günter, Zamarian, Laura, Löffler-Ragg, Judith, Helbok, Raimund, Kiechl, Stefan, Granata, Roberta, Wenning, Gregor K., Fanciulli, Alessandra
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2025
Springer Nature B.V
Predmet:
Adult
Aged
Autonomic Nervous System Diseases - epidemiology
Autonomic Nervous System Diseases - etiology
Cardiac arrhythmia
COVID-19
COVID-19 - complications
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
Diagnostics
Drug therapy
Dysautonomia
Fainting
Female
Humans
Hypotension
Infections
Intolerance
Male
Medical records
Medicine
Medicine & Public Health
Middle Aged
Neurology
Neuroradiology
Neurosciences
Original Communication
Pandemics
Postural Orthostatic Tachycardia Syndrome - diagnosis
Postural Orthostatic Tachycardia Syndrome - epidemiology
Postural Orthostatic Tachycardia Syndrome - etiology
Posture
Recurrent infection
Respiration
Retrospective Studies
Severe acute respiratory syndrome coronavirus 2
Statistical analysis
Syncope, Vasovagal - epidemiology
Syncope, Vasovagal - etiology
Tachycardia
Vaccination
Vaccination - adverse effects
Vasovagal syncope
Cardiovascular autonomic disorders
COVID-19
Infection
SARS-CoV-2
POTS
Vaccination
ISSN:0340-5354, 1432-1459, 1432-1459
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Background Cardiovascular autonomic disorders (CAD) were described following COVID-19 infection and vaccination, but previous reports were limited in size and follow-up. Here, we aimed to investigate the type and frequency of newly diagnosed and exacerbated CAD following COVID-19 infection or vaccination, and assessed their associated autonomic and non-autonomic complaints, applied treatment, and clinical outcome at last follow-up. Methods Medical records of individuals referred to the Innsbruck Dysautonomia Center between March 2020 and March 2023 were reviewed for new onset of orthostatic intolerance, recurrent syncope, OR exacerbation of previously diagnosed CAD within 6 weeks from a passed COVID-19 infection or vaccination. Results Following COVID-19 infection ( n  = 75), 22 (29%) individuals were diagnosed with postural orthostatic tachycardia syndrome (POTS), 12 (16%) with vasovagal syncope (VVS), 1 with delayed and 1 with transient orthostatic hypotension (OH). Following COVID-19 vaccination ( n  = 26), 11 (42%) POTS, 2 (8%) VVS, and 3 (12%) transient OH cases were newly diagnosed. In half of newly referred individuals ( n  = 49/101, 49%), the diagnostic workup excluded any CAD. VVS was the most frequently exacerbated CAD ( n  = 8/19, 42%). Non-pharmacological measures were recommended to all newly diagnosed CAD, with one-third additionally receiving pharmacotherapy. Follow-up was available in 42 (81%) individuals with newly diagnosed CAD, with a symptomatic improvement observed in 26 (62%) cases. Conclusion A specialized diagnostic workup is pivotal to diagnose or exclude CAD in individuals with new-onset orthostatic intolerance or recurrent syncope following COVID-19 infection or vaccination. A multimodal treatment approach can achieve a symptomatic improvement in a substantial proportion of affected individuals.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0340-5354
1432-1459
1432-1459
DOI:10.1007/s00415-025-13518-x